1. Home
  2. TTEK vs JAZZ Comparison

TTEK vs JAZZ Comparison

Compare TTEK & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

HOLD

Current Price

$37.24

Market Cap

9.5B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$168.93

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEK
JAZZ
Founded
1966
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
10.4B
IPO Year
1991
2007

Fundamental Metrics

Financial Performance
Metric
TTEK
JAZZ
Price
$37.24
$168.93
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
$43.25
$207.19
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
01-28-2026
02-24-2026
Dividend Yield
0.70%
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$4,617,360,000.00
$4,157,832,999.00
Revenue This Year
N/A
$6.00
Revenue Next Year
$6.70
$6.35
P/E Ratio
$39.97
N/A
Revenue Growth
6.84
4.14
52 Week Low
$27.27
$95.49
52 Week High
$42.98
$182.99

Technical Indicators

Market Signals
Indicator
TTEK
JAZZ
Relative Strength Index (RSI) 67.03 53.50
Support Level $33.73 $159.35
Resistance Level $36.38 $173.09
Average True Range (ATR) 0.92 5.80
MACD 0.30 -0.29
Stochastic Oscillator 95.95 65.44

Price Performance

Historical Comparison
TTEK
JAZZ

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: